Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1143

1.

Genomic characterization for familial cases with urothelial carcinoma.

Shindo T, Hirobe M, Adachi Y, Sasaki Y, Tokino T, Masumori N.

Int Cancer Conf J. 2019 Jun 27;8(4):185-189. doi: 10.1007/s13691-019-00381-7. eCollection 2019 Oct.

PMID:
31559120
2.

Panic disorders: The role of genetics and epigenetics.

Kim EJ, Kim YK.

AIMS Genet. 2018 Jul 27;5(3):177-190. doi: 10.3934/genet.2018.3.177. eCollection 2018. Review.

3.

Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer.

Wang X, Teng F, Lu J, Mu D, Zhang J, Yu J.

Cancer Manag Res. 2019 Jul 15;11:6593-6602. doi: 10.2147/CMAR.S204924. eCollection 2019.

4.

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.

D'Angelo A, Sobhani N, Roviello G, Bagby S, Bonazza D, Bottin C, Giudici F, Zanconati F, De Manzini N, Guglielmi A, Generali D.

PLoS One. 2019 Aug 5;14(8):e0219566. doi: 10.1371/journal.pone.0219566. eCollection 2019.

5.

miR-34a as hub of T cell regulation networks.

Hart M, Walch-Rückheim B, Krammes L, Kehl T, Rheinheimer S, Tänzer T, Glombitza B, Sester M, Lenhof HP, Keller A, Meese E.

J Immunother Cancer. 2019 Jul 16;7(1):187. doi: 10.1186/s40425-019-0670-5.

6.

Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.

Li X, Zhang Y, Chai X, Zhou S, Zhang H, He J, Zhou R, Cai L, Chen L, Tao G.

Am J Cancer Res. 2019 May 1;9(5):887-905. eCollection 2019.

7.

Coronary artery disease associated specific modules and feature genes revealed by integrative methods of WGCNA, MetaDE and machine learning.

Wang Y, Liu T, Liu Y, Chen J, Xin B, Wu M, Cui W.

Gene. 2019 Aug 20;710:122-130. doi: 10.1016/j.gene.2019.05.010. Epub 2019 May 7.

PMID:
31075415
8.

CXCL10 production induced by high levels of IKKε in nasal airway epithelial cells in the setting of chronic inflammation.

Nam YR, Lee KJ, Lee H, Joo CH.

Biochem Biophys Res Commun. 2019 Jun 30;514(3):607-612. doi: 10.1016/j.bbrc.2019.04.173. Epub 2019 May 6.

PMID:
31072618
9.

LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I.

Xian H, Yang S, Jin S, Zhang Y, Cui J.

Autophagy. 2019 May 22:1-11. doi: 10.1080/15548627.2019.1615303. [Epub ahead of print]

PMID:
31068071
10.

IKBKE inhibits TSC1 to activate the mTOR/S6K pathway for oncogenic transformation.

Göktuna Sİ.

Turk J Biol. 2018 Aug 9;42(4):268-278. doi: 10.3906/biy-1801-57. eCollection 2018.

11.

Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.

Yuan Y, Wang J, Chen Q, Wu Q, Deng W, Zhou H, Shen D.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1421-1427. doi: 10.1016/j.bbadis.2019.02.014. Epub 2019 Feb 19.

PMID:
30794866
12.

Constructing a High-Density Genetic Linkage Map for Large Yellow Croaker (Larimichthys crocea) and Mapping Resistance Trait Against Ciliate Parasite Cryptocaryon irritans.

Kong S, Ke Q, Chen L, Zhou Z, Pu F, Zhao J, Bai H, Peng W, Xu P.

Mar Biotechnol (NY). 2019 Apr;21(2):262-275. doi: 10.1007/s10126-019-09878-x. Epub 2019 Feb 19.

PMID:
30783862
13.

Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.

George G, Valiya Parambath S, Lokappa SB, Varkey J.

Gene. 2019 May 20;697:67-77. doi: 10.1016/j.gene.2019.02.026. Epub 2019 Feb 16.

PMID:
30776463
14.

Identification of an IKBKE inhibitor with antitumor activity in cancer cells overexpressing IKBKE.

Liu T, Gao X, Xin Y.

Cytokine. 2019 Apr;116:78-87. doi: 10.1016/j.cyto.2019.01.005. Epub 2019 Jan 24.

PMID:
30685606
15.

PSMB1 Negatively Regulates the Innate Antiviral Immunity by Facilitating Degradation of IKK-ε.

Wu F, Niu Z, Zhou B, Li P, Qian F.

Viruses. 2019 Jan 24;11(2). pii: E99. doi: 10.3390/v11020099.

16.

IKKε regulates the breast cancer stem cell phenotype.

Orlova Z, Pruefer F, Castro-Oropeza R, Ordaz-Ramos A, Zampedri C, Maldonado V, Vazquez-Santillan K, Melendez-Zajgla J.

Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):598-611. doi: 10.1016/j.bbamcr.2019.01.002. Epub 2019 Jan 5.

PMID:
30615901
17.

Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferons.

Brennan K, Lyons C, Fernandes P, Doyle S, Houston A, Brint E.

FEBS J. 2019 Feb;286(3):523-535. doi: 10.1111/febs.14727. Epub 2018 Dec 22.

PMID:
30536547
18.

PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.

Zhang Z, Wang Z, Huang K, Liu Y, Wei C, Zhou J, Zhang W, Wang Q, Liang H, Zhang A, Wang G, Zhen Y, Han L.

Cancer Lett. 2019 Feb 28;443:91-107. doi: 10.1016/j.canlet.2018.11.034. Epub 2018 Dec 4.

PMID:
30529153
19.

Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice.

Möser CV, Möller M, Fleck SC, Thomas D, Geisslinger G, Niederberger E.

Neuropharmacology. 2019 Mar 1;146:198-211. doi: 10.1016/j.neuropharm.2018.12.004. Epub 2018 Dec 6.

PMID:
30528326
20.

The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

Liu S, Marneth AE, Alexe G, Walker SR, Gandler HI, Ye DQ, Labella K, Mathur R, Toniolo PA, Tillgren M, Gokhale PC, Barbie D, Mullally A, Stegmaier K, Frank DA.

Blood Adv. 2018 Dec 11;2(23):3428-3442. doi: 10.1182/bloodadvances.2018016733.

Supplemental Content

Loading ...
Support Center